StockDrifts LogoStockDrifts

Access Bio 950130

Company
엑세스바이오Access Bio
Insiders
2
Buys
10
Total Value
₩229M ($159K)
Avg Return
-22.23%
Last Filing
2025-10-28

Access Bio (950130) has 10 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩229M ($159K) in reported transaction value. The earliest filing StockDrifts holds for Access Bio is dated 2025-10-14; the most recent is 2025-10-28. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -22.23%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-10-28BUYMarket Buy
박희덕
Park Hee-deok
moving4.0K₩4,130-16.5%₩17M ($12K)
2025-10-27BUYMarket Buy
박희덕
Park Hee-deok
moving2.2K₩4,005-13.9%₩9M ($6K)
2025-10-21BUYMarket Buy
박희덕
Park Hee-deok
moving5.4K₩4,265-19.1%₩23M ($16K)
2025-10-20BUYMarket Buy
박희덕
Park Hee-deok
moving4.0K₩4,380-21.2%₩17M ($12K)
2025-10-17BUYMarket Buy
박희덕
Park Hee-deok
moving3.3K₩4,375-21.1%₩14M ($10K)
2025-10-16BUYMarket Buy
박희덕
Park Hee-deok
moving8.3K₩4,620-25.3%₩38M ($27K)
2025-10-15BUYMarket Buy
박희덕
Park Hee-deok
moving7.5K₩4,640-25.6%₩35M ($24K)
2025-10-15BUYMarket Buy
이근형
Lee Geun-hyung
moving13.0K₩4,640-25.6%₩60M ($42K)
2025-10-15BUYMarket Buy
박희덕
Park Hee-deok
moving1.5K₩4,640-25.6%₩7M ($5K)
2025-10-14BUYMarket Buy
이근형
Lee Geun-hyung
moving1.5K₩4,810-28.3%₩7M ($5K)
2025-10-14BUY신규보고
박희덕
Park Hee-deok
moving3.0K₩4,810-28.3%₩14M ($10K)
2025-10-14BUY신규보고
이근형
Lee Geun-hyung
moving7.3K₩4,810-28.3%₩35M ($24K)

Frequently asked questions

Who has been buying Access Bio stock?
2 distinct insiders have filed 10 disclosed insider purchases in Access Bio (950130), most recently on 2025-10-28. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Access Bio have?
Access Bio has 10 buy-side and 0 sell-side disclosures on record, covering ₩229M ($159K) in total reported value, spanning 2025-10-14 to 2025-10-28.
Where does StockDrifts get Access Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Access Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.